Company intelligence / Profile preview

WELT

Seoul, South Koreawelt.de ↗

Ownership: Private
Development stage: Other

Overview

WELT has commercialized wearable devices like the "Smart Belt" and developed prescription digital therapeutic software such as PilLowRx/WELT-I for insomnia. The company’s DTx products are validated by clinical studies and have received regulatory approval/clearance in South Korea. Additional pipeline programs target psychiatric and chronic conditions with ongoing development and planned regulatory submissions over the next three years

Therapeutic areas: Psychiatry
Modalities: DeviceDigital therapeutics (DTx)Software as a medical device
Industry: Digital Health Medical Devices

Partnerships

Samsung Electronics (spin-off origin)Handok Pharmaceuticals (investor/collaborator)Korean government agencies including Ministry of Science & ICT and Ministry of Health & WelfareMajor hospitals/universities in Korea

Beyond the preview

Go deeper on WELT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WELT.

Explore the full profile